Literature DB >> 17828288

Neuropeptide Y Y2 receptor in health and disease.

S L Parker1, A Balasubramaniam.   

Abstract

We briefly survey the current knowledge and concepts regarding structure and function of the neuropeptide Y Y2 receptor and its agonists, especially as related to pharmacology of the receptor and its roles in pathological processes. Specific structural features are considered that could be responsible for the known compartmentalization and participation of the receptor in cell and tissue organization. This is further discussed in relation to changes of levels of the Y2 receptor in pathological conditions (especially in epilepsy and drug abuse), to endocytosis and recycling, and to participation in wound healing, retinopathy and angiogenesis. Properties of the receptor and of Y2 agonists are considered and reviewed in connection to the negative regulation of transmitter release, feeding, mood and social behavior. The possible involvement of the Y2 receptor in diabetes, carcinogenesis and bone formation is also reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828288      PMCID: PMC2241788          DOI: 10.1038/sj.bjp.0707445

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  155 in total

1.  Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.

Authors:  Hervé Gicquiaux; Sandra Lecat; Mireille Gaire; Alain Dieterlen; Yves Mély; Kenneth Takeda; Bernard Bucher; Jean-Luc Galzi
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

2.  Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

Authors:  Prasanth K Chelikani; Alvin C Haver; Joseph R Reeve; David A Keire; Roger D Reidelberger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-06       Impact factor: 3.619

3.  Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.

Authors:  A Souli; J Chariot; T Voisin; O Presset; A Tsocas; A Balasubramaniam; M Laburthe; C Rozé
Journal:  Peptides       Date:  1997       Impact factor: 3.750

4.  Role of the Y5 neuropeptide Y receptor in limbic seizures.

Authors:  D J Marsh; S C Baraban; G Hollopeter; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.

Authors:  A Balasubramaniam; Z Tao; W Zhai; M Stein; S Sheriff; W T Chance; J E Fischer; P E Eden; J E Taylor; C D Liu; D W McFadden; T Voisin; C Roze; M Laburthe
Journal:  J Med Chem       Date:  2000-09-07       Impact factor: 7.446

6.  The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.

Authors:  Bouchaïb El Bahh; Silvia Balosso; Trevor Hamilton; Herbert Herzog; Annette G Beck-Sickinger; Günther Sperk; Donald R Gehlert; Annamaria Vezzani; William F Colmers
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

7.  Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.

Authors:  T Nilsson; H Lind; J Brunkvall; L Edvinsson
Journal:  Can J Physiol Pharmacol       Date:  2000-03       Impact factor: 2.273

8.  Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.

Authors:  D A Ammar; B A Hughes; D A Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-09       Impact factor: 4.799

9.  Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.

Authors:  I Castan; P Valet; N Quideau; T Voisin; L Ambid; M Laburthe; M Lafontan; C Carpéné
Journal:  Am J Physiol       Date:  1994-04

10.  Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally.

Authors:  Monique Caillol; Josiane Aïoun; Christine Baly; Marie-Annick Persuy; Roland Salesse
Journal:  Brain Res       Date:  2003-01-17       Impact factor: 3.252

View more
  25 in total

1.  Surface masking shapes the traffic of the neuropeptide Y Y2 receptor.

Authors:  Michael S Parker; Renu Sah; Steven L Parker
Journal:  Peptides       Date:  2012-06-23       Impact factor: 3.750

2.  Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-04-08       Impact factor: 3.332

3.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

4.  GPCR theme editorial.

Authors:  G Milligan; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

5.  Astrocytes control synaptic strength by two distinct v-SNARE-dependent release pathways.

Authors:  Yvonne Schwarz; Na Zhao; Frank Kirchhoff; Dieter Bruns
Journal:  Nat Neurosci       Date:  2017-09-25       Impact factor: 24.884

6.  Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.

Authors:  M S Parker; R Sah; A Balasubramaniam; F R Sallee; O Zerbe; S L Parker
Journal:  Peptides       Date:  2010-11-30       Impact factor: 3.750

7.  Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists.

Authors:  Gopi Kumar Mittapalli; Danielle Vellucci; Jun Yang; Marion Toussaint; Shaun P Brothers; Claes Wahlestedt; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

8.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.

Authors:  Brenna M Flannery; Erica S Clark; James J Pestka
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

Review 9.  Ligands of the neuropeptide Y Y2 receptor.

Authors:  Gopi Kumar Mittapalli; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2013-12-04       Impact factor: 2.823

10.  Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor.

Authors:  Steven L Parker; Michael S Parker; Ying Y Wong; Renu Sah; Ambikaipakan Balasubramaniam; Floyd Sallee
Journal:  Eur J Pharmacol       Date:  2008-07-30       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.